English
简体中文
Total: £ 56.28
Published Date: 2024-08-02 | Pages: 74 | Tables: 106 | Medical Care
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
Market Analysis and Insights: Global PD-L1 Biomarker Testing Market
The global PD-L1 Biomarker Testing market is projected to grow from US$ 2088 million in 2024 to US$ 14870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 38.7% during the forecast period.
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
Report Covers:
This report presents an overview of global market for PD-L1 Biomarker Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of PD-L1 Biomarker Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for PD-L1 Biomarker Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the PD-L1 Biomarker Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global PD-L1 Biomarker Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for PD-L1 Biomarker Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Agilent Technologies
Roche
Segment by Type
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Segment by Application
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of PD-L1 Biomarker Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 Biomarker Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PD-L1 Biomarker Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PD-L1 (22C3)
1.2.3 PD-L1(28-8)
1.2.4 PD-L1 (SP142)
1.2.5 PD-L1 (SP263)
1.2.6 Other
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2019-2030)
2.2 Global PD-L1 Biomarker Testing Growth Trends by Region
2.2.1 PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2019-2024)
2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030)
2.3 PD-L1 Biomarker Testing Market Dynamics
2.3.1 PD-L1 Biomarker Testing Industry Trends
2.3.2 PD-L1 Biomarker Testing Market Drivers
2.3.3 PD-L1 Biomarker Testing Market Challenges
2.3.4 PD-L1 Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue PD-L1 Biomarker Testing by Players
3.1.1 Global PD-L1 Biomarker Testing Revenue by Players (2019-2024)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2019-2024)
3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of PD-L1 Biomarker Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2023
3.5 Global Key Players of PD-L1 Biomarker Testing Head office and Area Served
3.6 Global Key Players of PD-L1 Biomarker Testing, Product and Application
3.7 Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2019-2024)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030)
5 PD-L1 Biomarker Testing Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2019-2024)
5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PD-L1 Biomarker Testing Market Size (2019-2030)
6.2 North America PD-L1 Biomarker Testing Market Size by Type
6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2019-2024)
6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2025-2030)
6.2.3 North America PD-L1 Biomarker Testing Market Share by Type (2019-2030)
6.3 North America PD-L1 Biomarker Testing Market Size by Application
6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2019-2024)
6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2025-2030)
6.3.3 North America PD-L1 Biomarker Testing Market Share by Application (2019-2030)
6.4 North America PD-L1 Biomarker Testing Market Size by Country
6.4.1 North America PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2019-2024)
6.4.3 North America PD-L1 Biomarker Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe PD-L1 Biomarker Testing Market Size (2019-2030)
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2019-2024)
7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2025-2030)
7.2.3 Europe PD-L1 Biomarker Testing Market Share by Type (2019-2030)
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2019-2024)
7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2025-2030)
7.3.3 Europe PD-L1 Biomarker Testing Market Share by Application (2019-2030)
7.4 Europe PD-L1 Biomarker Testing Market Size by Country
7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024)
7.4.3 Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China PD-L1 Biomarker Testing Market Size (2019-2030)
8.2 China PD-L1 Biomarker Testing Market Size by Type
8.2.1 China PD-L1 Biomarker Testing Market Size by Type (2019-2024)
8.2.2 China PD-L1 Biomarker Testing Market Size by Type (2025-2030)
8.2.3 China PD-L1 Biomarker Testing Market Share by Type (2019-2030)
8.3 China PD-L1 Biomarker Testing Market Size by Application
8.3.1 China PD-L1 Biomarker Testing Market Size by Application (2019-2024)
8.3.2 China PD-L1 Biomarker Testing Market Size by Application (2025-2030)
8.3.3 China PD-L1 Biomarker Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia PD-L1 Biomarker Testing Market Size (2019-2030)
9.2 Asia PD-L1 Biomarker Testing Market Size by Type
9.2.1 Asia PD-L1 Biomarker Testing Market Size by Type (2019-2024)
9.2.2 Asia PD-L1 Biomarker Testing Market Size by Type (2025-2030)
9.2.3 Asia PD-L1 Biomarker Testing Market Share by Type (2019-2030)
9.3 Asia PD-L1 Biomarker Testing Market Size by Application
9.3.1 Asia PD-L1 Biomarker Testing Market Size by Application (2019-2024)
9.3.2 Asia PD-L1 Biomarker Testing Market Size by Application (2025-2030)
9.3.3 Asia PD-L1 Biomarker Testing Market Share by Application (2019-2030)
9.4 Asia PD-L1 Biomarker Testing Market Size by Region
9.4.1 Asia PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia PD-L1 Biomarker Testing Market Size by Region (2019-2024)
9.4.3 Asia PD-L1 Biomarker Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024)
11.1.5 Agilent Technologies Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 Biomarker Testing Introduction
11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024)
11.2.5 Roche Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of PD-L1 (22C3)
Table 3. Key Players of PD-L1(28-8)
Table 4. Key Players of PD-L1 (SP142)
Table 5. Key Players of PD-L1 (SP263)
Table 6. Key Players of Other
Table 7. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global PD-L1 Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global PD-L1 Biomarker Testing Market Share by Region (2019-2024)
Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global PD-L1 Biomarker Testing Market Share by Region (2025-2030)
Table 13. PD-L1 Biomarker Testing Market Trends
Table 14. PD-L1 Biomarker Testing Market Drivers
Table 15. PD-L1 Biomarker Testing Market Challenges
Table 16. PD-L1 Biomarker Testing Market Restraints
Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global PD-L1 Biomarker Testing Revenue Share by Players (2019-2024)
Table 19. Global Top PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2023)
Table 20. Global PD-L1 Biomarker Testing Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of PD-L1 Biomarker Testing, Headquarters and Area Served
Table 23. Global Key Players of PD-L1 Biomarker Testing, Product and Application
Table 24. Global Key Players of PD-L1 Biomarker Testing, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2019-2024)
Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2025-2030)
Table 30. Global PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global PD-L1 Biomarker Testing Revenue Share by Application (2019-2024)
Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global PD-L1 Biomarker Testing Revenue Share by Application (2025-2030)
Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America PD-L1 Biomarker Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe PD-L1 Biomarker Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. China PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 49. China PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)
Table 50. China PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 51. China PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia PD-L1 Biomarker Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia PD-L1 Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia PD-L1 Biomarker Testing Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 66. Agilent Technologies Company Details
Table 67. Agilent Technologies Business Overview
Table 68. Agilent Technologies PD-L1 Biomarker Testing Product
Table 69. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)
Table 70. Agilent Technologies Recent Developments
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche PD-L1 Biomarker Testing Product
Table 74. Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)
Table 75. Roche Recent Developments
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global PD-L1 Biomarker Testing Market Share by Type: 2023 VS 2030
Figure 3. PD-L1 (22C3) Features
Figure 4. PD-L1(28-8) Features
Figure 5. PD-L1 (SP142) Features
Figure 6. PD-L1 (SP263) Features
Figure 7. Other Features
Figure 8. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global PD-L1 Biomarker Testing Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Diagnostic Center Case Studies
Figure 12. Others Case Studies
Figure 13. PD-L1 Biomarker Testing Report Years Considered
Figure 14. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global PD-L1 Biomarker Testing Market Share by Region: 2023 VS 2030
Figure 17. Global PD-L1 Biomarker Testing Market Share by Players in 2023
Figure 18. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2023
Figure 20. North America PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America PD-L1 Biomarker Testing Market Share by Type (2019-2030)
Figure 22. North America PD-L1 Biomarker Testing Market Share by Application (2019-2030)
Figure 23. North America PD-L1 Biomarker Testing Market Share by Country (2019-2030)
Figure 24. United States PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe PD-L1 Biomarker Testing Market Share by Type (2019-2030)
Figure 28. Europe PD-L1 Biomarker Testing Market Share by Application (2019-2030)
Figure 29. Europe PD-L1 Biomarker Testing Market Share by Country (2019-2030)
Figure 30. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China PD-L1 Biomarker Testing Market Share by Type (2019-2030)
Figure 38. China PD-L1 Biomarker Testing Market Share by Application (2019-2030)
Figure 39. Asia PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia PD-L1 Biomarker Testing Market Share by Type (2019-2030)
Figure 41. Asia PD-L1 Biomarker Testing Market Share by Application (2019-2030)
Figure 42. Asia PD-L1 Biomarker Testing Market Share by Region (2019-2030)
Figure 43. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Country (2019-2030)
Figure 53. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
